fashion -WSS

fashion

author：entertainment 2025-09-28 21:04:45 - browse：212

Stock photograph of a tall pile of journals or magazines on a black background — Adobe

There was a time when an allegation of data mishandling, scientific misconduct, or just a technical error felt like a crisis to Barrett Rollins, an oncologist and research integrity officer at Dana-Farber Cancer Institute. Now, it’s a Tuesday.

The renowned cancer treatment and research center is in the midst of a lengthy review of possible discrepancies involving around 60 papers co-authored by four of its top researchers over a period of over 15 years, including CEO Laurie Glimcher and COO William Hahn. And it’s hardly alone. Over the past decade, the number of research misconduct allegations reported to the National Institutes of Health has more than doubled, climbing from 74 in 2013 to 169 in 2022. And scientific sleuths are finding plenty of other problems that don’t always qualify as outright misconduct.

One analysis of PubPeer, a website where users can anonymously comment on scientific papers, found that out of a sample of nearly 25,000 comments, 62% were about alleged data manipulation. Nearly 80% of these comments were on health or life sciences studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

WSS

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Why failed clinical trials don’t always spell doom for a new drug

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

National panel will explore requiring free Covid tests

focus

fashion

Wikipedia

Apple is now the first public company to be valued at $3 trillion

Trump indictment: Who are the 'co

Bright Health sells Medicare Advantage business to Molina

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Jerome Adams on the need for new antivirals for Covid

Amazon expands telehealth clinic nationwide

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

American woman, child freed after being kidnapped in Haiti last month

How to save PrEP access — and even expand it

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

knowledge

Anavex keeps shifting the goalposts in its clinical trials

Sage hopes for a blockbuster in antidepressant now before FDA

Wegovy’s successful heart trial raises vital question about weight loss

Physician groups backed by private equity giant lobby on mergers

NIH launches clinical trials and new research office for long Covid

Micronoma's microbiome cancer diagnostic approach under fire

leisure time

entertainment

entertainment

entertainment